This study is looking at how well a drug called ART4215 works either alone or when combined with the talazoparib in people with different types of advanced cancers. ART4215 is an oral, that is designed to keep cancer cells from repairing damage.

This study is no longer recruiting patients.

This Study is Open To:

This study is no longer recruiting patients.

This Study is NOT Open To:

This study is no longer recruiting patients.

Study Contact Information:

Study coordinator:
Michael Courtland
MJCourtland@mdanderson.org

Study Contact Information:

A Study of the Investigational Targeted Therapy ART4215 to Treat Advanced or Metastatic Solid Tumors

Study Contact Information:

About the Study

This study is no longer recruiting patients.

This Study is Open To:

This Study is NOT Open To:

Study Contact Information:

Knowledge Can Save Lives